A Multiple-Dose Study to Assess the Safety, Tolerability, and Steady State Pharmacokinetics of APD791 in Healthy Volunteers

The APD791-002 study is designed primarily to evaluate the safety, tolerability, and pharmacokinetics of APD791 when administered for 7 days to healthy adult subjects.

Inclusion Criteria:

• Healthy adult men and women, ages 19-45
• Non smokers

Exclusion Criteria:

• History of a bleeding disorder
• Use of any drug known to have an effect on coagulation or clotting or any anti-platelet therapy within 2 weeks of the screening
• Recently donated blood or had significant blood loss
• Current use of a prescription medication
• Pregnant females